Testing NNC0487-0111 to regulate insulin in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–75 years old
- You were diagnosed with type 2 diabetes at least 6 months ago
- You take only metformin, or metformin plus an SGLT2 inhibitor (a water-pill type diabetes medication), and have been on a stable dose for at least 3 months
- Your blood sugar control (HbA1c) is in the target range: 6.5–9.5% on metformin alone, or 6.0–9.0% on metformin plus SGLT2i
- You have not had significant weight changes (5% or more) or tried to lose weight in the past 3 months
- You do not have a history of heart attack, stroke, or serious heart problems in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.